Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- United States
- United Kingdom
- Canada
- Israel
- Germany
- France
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
- Precision Medicine
- Diagnostics
- Medical Devices
- Digital Health
About
BCRF Ventures is a New York-based venture capital firm focused on accelerating breast cancer innovations from research to clinical impact. Their focus spans breast cancer therapeutics, precision medicine, diagnostics, and digital health across the United States, United Kingdom, Canada, Israel, Germany, and France. The firm supports oncology founders from seed through Series B stages.
BCRF Ventures is a New York-based venture capital firm focused on accelerating breast cancer innovations from research to clinical impact. Their focus spans breast cancer therapeutics, precision medicine, diagnostics, and digital health across the United States, United Kingdom, Canada, Israel, Germany, and France. The firm supports oncology founders from seed through Series B stages.
Investment Thesis
BCRF Ventures is a seed to Series B stage venture capital firm deploying capital across breast cancer therapeutics, precision medicine, diagnostics, biotech, medical devices, digital health, and oncology sectors. They invest in early-stage companies commercializing breast cancer innovations emerging from Breast Cancer Research Foundation-funded research and broader oncology innovation. The firm differentiates itself as the venture arm of the Breast Cancer Research Foundation (largest private funder of breast cancer research globally), providing scientific expertise, clinical networks, and mission-aligned capital to accelerate breast cancer breakthroughs.
Manager's Experience
Launched in 2024 as the venture arm of the Breast Cancer Research Foundation (largest private funder of breast cancer research globally). Led by Dr. Dorraya El-Ashry (Chief Scientific Officer of BCRF, oversees investment strategy). Team combines BCRF's scientific expertise with venture investing capabilities. Focused on accelerating breast cancer innovations from research to clinical impact through direct investments in oncology-focused biotech, precision medicine, and digital health startups. Backed by BCRF's donor network and mission-aligned institutional partners.
Team
Dr. Dorraya El-Ashry - Chief Scientific Officer of BCRF (oversees investment strategy)
Portfolio
Clairity
Inc.